TCF — Theracryf Share News
0.000.00%
Brief: Theracryf Signs Master Service Agreement For Orexin-1 Programme Development
Board Appointment, Grant of Options, PDMR Dealing
Investor webinar
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Director/PDMR Shareholding
Holding(s) in Company
Brief: Theracryf Raises £4.25 Million Via Placing, Subscription
Brief: Theracryf Appoints Alastair Smith As Chair